Veracyte, Inc. (VCYT)
USD 30.35
(2.15%)
USD 30.35
(2.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 248.14 Million USD | 14.46% |
| 2022 | 194.95 Million USD | 34.35% |
| 2021 | 145.11 Million USD | 90.87% |
| 2020 | 76.02 Million USD | -9.32% |
| 2019 | 83.84 Million USD | 42.28% |
| 2018 | 58.93 Million USD | 34.67% |
| 2017 | 43.75 Million USD | 10.44% |
| 2016 | 39.62 Million USD | 41.48% |
| 2015 | 28 Million USD | 29.75% |
| 2014 | 21.58 Million USD | 132.66% |
| 2013 | 9.27 Million USD | 129.4% |
| 2012 | 4.04 Million USD | 1544.29% |
| 2011 | -280 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 75.78 Million USD | 25.21% |
| 2023 Q1 | 60.63 Million USD | 7.9% |
| 2023 Q2 | 62.49 Million USD | 3.07% |
| 2023 Q4 | 60.52 Million USD | -4.16% |
| 2023 Q3 | 63.15 Million USD | 1.05% |
| 2023 FY | 223.15 Million USD | 14.46% |
| 2022 Q1 | 47.83 Million USD | 8.54% |
| 2022 Q4 | 56.19 Million USD | 5.1% |
| 2022 FY | 194.95 Million USD | 34.35% |
| 2022 Q3 | 53.46 Million USD | 7.83% |
| 2022 Q2 | 49.58 Million USD | 3.66% |
| 2021 Q1 | 37.63 Million USD | 54.87% |
| 2021 Q2 | 38.72 Million USD | 2.91% |
| 2021 FY | 145.11 Million USD | 90.87% |
| 2021 Q3 | 44.45 Million USD | 14.79% |
| 2021 Q4 | 44.07 Million USD | -0.86% |
| 2020 Q2 | 20.75 Million USD | 59.02% |
| 2020 Q4 | 24.3 Million USD | 4.07% |
| 2020 Q1 | 13.04 Million USD | -30.88% |
| 2020 FY | 76.02 Million USD | -9.32% |
| 2020 Q3 | 23.34 Million USD | 12.52% |
| 2019 Q3 | 19.61 Million USD | -10.28% |
| 2019 Q4 | 18.87 Million USD | -3.73% |
| 2019 FY | 83.84 Million USD | 42.28% |
| 2019 Q1 | 21.35 Million USD | 1.63% |
| 2019 Q2 | 21.85 Million USD | 2.34% |
| 2018 Q2 | 15.2 Million USD | 4.83% |
| 2018 Q3 | 17.04 Million USD | 12.11% |
| 2018 Q4 | 21.01 Million USD | 23.29% |
| 2018 FY | 58.93 Million USD | 34.67% |
| 2018 Q1 | 14.5 Million USD | 19.15% |
| 2017 Q3 | 11.82 Million USD | 14.27% |
| 2017 Q4 | 12.17 Million USD | 2.93% |
| 2017 FY | 43.75 Million USD | 10.44% |
| 2017 Q1 | 11.44 Million USD | 12.94% |
| 2017 Q2 | 10.35 Million USD | -9.58% |
| 2016 Q1 | 8.37 Million USD | 15.17% |
| 2016 FY | 39.62 Million USD | 41.48% |
| 2016 Q2 | 12.23 Million USD | 46.12% |
| 2016 Q4 | 10.13 Million USD | -13.69% |
| 2016 Q3 | 11.74 Million USD | -4.04% |
| 2015 Q2 | 6.71 Million USD | -0.77% |
| 2015 FY | 28 Million USD | 29.75% |
| 2015 Q4 | 7.27 Million USD | -7.58% |
| 2015 Q3 | 7.86 Million USD | 17.12% |
| 2015 Q1 | 6.76 Million USD | 1.76% |
| 2014 Q2 | 5.67 Million USD | 20.36% |
| 2014 FY | 21.58 Million USD | 132.66% |
| 2014 Q4 | 6.65 Million USD | -9.3% |
| 2014 Q3 | 7.33 Million USD | 29.35% |
| 2014 Q1 | 4.71 Million USD | 21.76% |
| 2013 Q2 | 2.46 Million USD | 34.02% |
| 2013 Q4 | 3.86 Million USD | 14.91% |
| 2013 Q1 | 1.83 Million USD | 14.03% |
| 2013 FY | 9.27 Million USD | 129.4% |
| 2013 Q3 | 3.36 Million USD | 36.76% |
| 2012 FY | 4.04 Million USD | 1544.29% |
| 2012 Q4 | 1.61 Million USD | -13.25% |
| 2012 Q3 | 1.85 Million USD | 49.76% |
| 2012 Q2 | 1.24 Million USD | 0.0% |
| 2011 FY | -280 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 647.486% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 333.831% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1078.235% |
| Autolus Therapeutics plc | -4.86 Million USD | 5198.582% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6870199.668% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 29818.323% |
| Shattuck Labs, Inc. | -2.38 Million USD | 10504.528% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 10409.431% |
| CervoMed Inc. | -1.29 Million USD | 19282.345% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3596.027% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 896.171% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 52391.774% |
| Precision BioSciences, Inc. | 40.47 Million USD | -513.135% |
| Dyadic International, Inc. | 922.95 Thousand USD | -26786.193% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 469.796% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 168908.163% |
| Nektar Therapeutics | 53.47 Million USD | -364.019% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -150.556% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -58425.472% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -499.594% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 58214.286% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -161.972% |
| GRI Bio, Inc. | 10.84 Million USD | -2188.977% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -9669.66% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2956.544% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 255922.68% |
| Psyence Biomedical Ltd. | -240.00 USD | 103395100.0% |
| IGM Biosciences, Inc. | -211.66 Million USD | 217.239% |
| INmune Bio, Inc. | 155 Thousand USD | -159995.484% |
| Opthea Limited | 21.72 Thousand USD | -1142386.188% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -61628.358% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 495.297% |
| Verastem, Inc. | -62 Thousand USD | 400338.71% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -10090.883% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 95175.862% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -8097.82% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -107.217% |
| NextCure, Inc. | -3.68 Million USD | 6835.831% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1957.694% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4704.713% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 71.8 Million USD | -245.61% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 20695.246% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1137.522% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 30288.321% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3990.516% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -60.312% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 352.653% |
| Senti Biosciences, Inc. | -2.68 Million USD | 9348.9% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -170097.531% |
| Apollomics, Inc. | 127 Thousand USD | -195292.126% |
| PureTech Health plc | -1.6 Million USD | 15580.225% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 956.628% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -30841.147% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 324.591% |
| Synaptogenix, Inc. | -6347.00 USD | 3909789.617% |
| ChromaDex Corporation | 50.78 Million USD | -388.673% |
| Beam Therapeutics Inc. | -59.67 Million USD | 515.853% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -105.976% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 321.243% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 26.601% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 4064.026% |
| Mesoblast Limited | -9.81 Million USD | 2628.253% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -83.448% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 352.792% |
| MediWound Ltd. | 3.57 Million USD | -6835.383% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -206690.0% |
| Fortress Biotech, Inc. | 57.85 Million USD | -328.928% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -576988.372% |
| Achilles Therapeutics plc | -4.73 Million USD | 5344.853% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -97.537% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 670.941% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1079004.348% |
| Zai Lab Limited | 170.9 Million USD | -45.198% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2999.525% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -190783.077% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -39.531% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1465.208% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.551% |
| FibroGen, Inc. | 128.9 Million USD | -92.506% |
| Celcuity Inc. | -142.77 Thousand USD | 173907.189% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| ContextLogic Inc. | 59 Million USD | -320.59% |
| GH Research PLC | -315 Thousand USD | 78877.143% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1396.942% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -63691.26% |
| ImmuCell Corporation | 4.39 Million USD | -5544.494% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 30.167% |
| Amarin Corporation plc | 165.54 Million USD | -49.901% |
| TG Therapeutics, Inc. | 219.1 Million USD | -13.254% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 43865.079% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 22496.029% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 428.525% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -238.062% |
| Aptorum Group Limited | -1.11 Million USD | 22361.655% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 36.215% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 24.056% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 371428.954% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -3.079% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 48121.272% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 7088.116% |
| Ardelyx, Inc. | 106.66 Million USD | -132.651% |
| Ainos, Inc. | -253.73 Thousand USD | 97898.867% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 633.985% |
| Prothena Corporation plc | -129.2 Million USD | 292.064% |
| HilleVax, Inc. | -2.15 Million USD | 11609.647% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -392.123% |
| Celularity Inc. | 6.75 Million USD | -3573.546% |
| Rallybio Corporation | -150 Thousand USD | 165532.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 861.027% |
| Omeros Corporation | -69.77 Million USD | 455.62% |
| Humacyte, Inc. | -76.55 Million USD | 424.165% |
| Immunocore Holdings plc | 248.39 Million USD | 0.098% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1735.889% |
| Blueprint Medicines Corporation | 236.58 Million USD | -4.888% |
| IO Biotech, Inc. | -756 Thousand USD | 32923.81% |
| MEI Pharma, Inc. | 49.32 Million USD | -403.067% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 17501.683% |
| Summit Therapeutics Inc. | -2.05 Million USD | 12204.78% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 5271.905% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -754.063% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 8825.316% |
| Pulmatrix, Inc. | -8.22 Million USD | 3118.832% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 21309.231% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 12532.265% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 62292.481% |
| Acelyrin, Inc. | -115 Thousand USD | 215880.87% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 162.225% |
| Cytokinetics, Incorporated | -322.59 Million USD | 176.923% |
| Vor Biopharma Inc. | -3.49 Million USD | 7206.186% |
| Evogene Ltd. | 1.39 Million USD | -17637.527% |
| Replimune Group, Inc. | -2.65 Million USD | 9446.441% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 665.103% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 432971.646% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3518.9% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -22296.029% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 752063.636% |
| Atai Life Sciences N.V. | -5000.00 USD | 4963060.0% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 258587.5% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -49929.839% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 17965.227% |
| Sagimet Biosciences Inc. | 2 Million USD | -12307.4% |
| MediciNova, Inc. | 979.7 Thousand USD | -25228.849% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 394.297% |
| MiMedx Group, Inc. | 266.84 Million USD | 7.006% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 262537.735% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -1.477% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 71.554% |
| Mereo BioPharma Group plc | 7.42 Million USD | -3241.611% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2068000.0% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4963060.0% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 10183.218% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 4140.84% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2436.782% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 459.656% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 47.856% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2175310.379% |
| Precigen, Inc. | 106 Thousand USD | -234001.887% |
| XOMA Corporation | 3.86 Million USD | -6327.04% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 454.067% |
| Incyte Corporation | 3.44 Billion USD | 92.788% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 489157.942% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1577.356% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1891.557% |
| Seer, Inc. | 7.02 Million USD | -3431.351% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | -2.985% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 855782.759% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1908830669.231% |
| Akari Therapeutics, Plc | -4000.00 USD | 6203800.0% |
| Novavax, Inc. | 639.93 Million USD | 61.223% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -127346.227% |
| UroGen Pharma Ltd. | 73.35 Million USD | -238.298% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1029.602% |
| Entera Bio Ltd. | -56 Thousand USD | 443221.429% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 131395.238% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -6025.599% |
| Chimerix, Inc. | 324 Thousand USD | -76488.889% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 47366.286% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -48084.078% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 561673.278% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 92.699% |
| AnaptysBio, Inc. | 14.78 Million USD | -1578.831% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -42967.866% |
| Portage Biotech Inc. | -54 Thousand USD | 459633.333% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 65921.751% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 19841.289% |
| OKYO Pharma Limited | -7506.16 USD | 3306024.734% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 5520633.927% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 12532827.273% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 111778478.378% |
| AbCellera Biologics Inc. | 38.02 Million USD | -552.592% |
| Genprex, Inc. | -15 Thousand USD | 1653978.966% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 37247.904% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2175310.379% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 2.76 Million USD | -8859.958% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 14452.111% |
| Bicycle Therapeutics plc | -129.52 Million USD | 291.59% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 162.089% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -337.743% |
| Erasca, Inc. | -3.73 Million USD | 6749.196% |
| bluebird bio, Inc. | -4.03 Million USD | 6257.519% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -24493.459% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 86.97% |
| DBV Technologies S.A. | 15.72 Million USD | -1477.747% |
| Fortress Biotech, Inc. | 57.85 Million USD | -328.928% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 236.79% |
| CorMedix Inc. | -205.56 Thousand USD | 120816.864% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -85.479% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 43558.494% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -9540.559% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 730.73% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 323.299% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -914.879% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 7016.054% |
| Onconetix, Inc. | -1.12 Million USD | 22115.233% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1203.093% |
| Prime Medicine, Inc. | -147.9 Million USD | 267.775% |
| Adagene Inc. | 18.11 Million USD | -1270.114% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -40646.798% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 173265.575% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -76.993% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 243.282% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -57.219% |
| SciSparc Ltd. | 2.19 Million USD | -11200.0% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 990750.325% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 801042.483% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -157.5% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -354.325% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3592.26% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 83.652% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -152.47% |
| ADMA Biologics, Inc. | 88.21 Million USD | -181.29% |
| Clene Inc. | 533 Thousand USD | -46456.848% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -929.268% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 26029.781% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -12382.294% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 127803.329% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -398.239% |
| Absci Corporation | -41.84 Million USD | 692.96% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.804% |
| Surrozen, Inc. | -27.23 Million USD | 1011.304% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 419.787% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 629.789% |
| Cingulate Inc. | -582.91 Thousand USD | 42669.967% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 800577.419% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 3278144.914% |
| Jaguar Health, Inc. | 7.72 Million USD | -3112.688% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 28266.629% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 63.545% |
| Kronos Bio, Inc. | 1.37 Million USD | -17986.589% |
| Innoviva, Inc. | 261.06 Million USD | 4.948% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 562.393% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -751.893% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2386138.462% |
| Soligenix, Inc. | 97.31 Thousand USD | -254905.087% |
| AlloVir, Inc. | -398 Thousand USD | 62448.744% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2395.754% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 24145.349% |
| Kura Oncology, Inc. | -849 Thousand USD | 29328.269% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 147807.143% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -300.633% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16574.108% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 38367.633% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 847773.704% |
| HCW Biologics Inc. | -574.82 Thousand USD | 43269.387% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 355.955% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 79380.511% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -162.699% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 142026.185% |
| Histogen Inc. | 3.76 Million USD | -6483.921% |
| Surrozen, Inc. | -27.23 Million USD | 1011.304% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 66449.733% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1056.365% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1886009.713% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 369747.406% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 12240.313% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -38673.125% |
| Moderna, Inc. | 2.15 Billion USD | 88.485% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 68.125% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1403.381% |
| Immix Biopharma, Inc. | -5468.00 USD | 4538285.808% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 486664.706% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -53.781% |
| Exelixis, Inc. | 1.75 Billion USD | 85.882% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 4088.235% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -138.377% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 81.949% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 22496.029% |
| Arcellx, Inc. | 108.27 Million USD | -129.175% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 209523.501% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -3290.926% |
| Insmed Incorporated | 239.63 Million USD | -3.552% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 866.622% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -213.302% |
| Moolec Science SA | -143.3 Thousand USD | 173260.741% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 686.389% |
| Geron Corporation | -123.5 Million USD | 300.925% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -7449.376% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -5568.068% |
| Royalty Pharma plc | 1.79 Billion USD | 86.167% |
| OmniAb, Inc. | 14.66 Million USD | -1591.88% |
| Alector, Inc. | -95.05 Million USD | 361.063% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 454.042% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 322.726% |
| Humacyte, Inc. | -76.55 Million USD | 424.165% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 26243.573% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -203.074% |
| 89bio, Inc. | -273 Thousand USD | 90996.703% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | -1.29 Million USD | 19262.008% |
| Immunic, Inc. | -111 Thousand USD | 223656.757% |
| Genelux Corporation | -848 Thousand USD | 29362.736% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 201846.341% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 43997972.34% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2226.943% |
| Immunovant, Inc. | -231 Thousand USD | 107523.377% |
| Vericel Corporation | 135.57 Million USD | -83.032% |
| Fortrea Holdings Inc. | 424 Million USD | 41.475% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 387.985% |
| XBiotech Inc. | -1.74 Million USD | 14328.67% |
| Agenus Inc. | 139.61 Million USD | -77.737% |
| Acasti Pharma Inc. | -11 Thousand USD | 2255990.909% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 6262.049% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 121374.381% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 38367.633% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1376.808% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 599.825% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2291.376% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 65230.709% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1228.612% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -264.249% |
| United Therapeutics Corporation | 2.07 Billion USD | 88.012% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4595233.333% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 300583.15% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -374383.883% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 6394.901% |
| Pharming Group N.V. | 220.1 Million USD | -12.741% |
| XOMA Corporation | 3.86 Million USD | -6327.04% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 57217.867% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 23205.028% |
| Pyxis Oncology, Inc. | -2 Million USD | 12507.4% |
| uniQure N.V. | 2.21 Million USD | -11103.07% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 13160.421% |
| Cassava Sciences, Inc. | -89.42 Million USD | 377.499% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 112395.85% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 302719.512% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 369.524% |
| Pluri Inc. | 322 Thousand USD | -76964.596% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 287 Thousand USD | -86362.718% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -297.788% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2475.769% |
| CalciMedica, Inc. | -58 Thousand USD | 427941.379% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 903.979% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 31.457% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2468988.668% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 23205.028% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -8840.386% |
| Nutriband Inc. | 862.1 Thousand USD | -28683.965% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 72870.674% |
| Compugen Ltd. | 31.45 Million USD | -688.898% |
| Roivant Sciences Ltd. | 109.23 Million USD | -127.169% |
| ProKidney Corp. | -3.16 Million USD | 7930.483% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 879496.13% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -21771.353% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 415.425% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 203735.349% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -912.188% |
| Benitec Biopharma Inc. | 108 Thousand USD | -229666.667% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1297.581% |
| Biomea Fusion, Inc. | -4.2 Million USD | 6006.879% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 80147.742% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 424.916% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -16.101% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1183.758% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 318238.462% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 26470.67% |
| Imunon, Inc. | -720 Thousand USD | 34564.761% |
| BioAtla, Inc. | -103.73 Million USD | 339.223% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 202.195% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 79890.354% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | -2.38 Million USD | 10491.457% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 47186.907% |
| Viridian Therapeutics, Inc. | -1 Million USD | 24717.857% |
| Galecto, Inc. | -830 Thousand USD | 29997.349% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 61.038% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -22075.871% |
| PolyPid Ltd. | -1.82 Million USD | 13719.539% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 208627.731% |
| Forte Biosciences, Inc. | -9000.00 USD | 2757300.0% |
| Xencor, Inc. | -85.26 Million USD | 391.049% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 24884.167% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -127346.227% |
| Instil Bio, Inc. | -4.75 Million USD | 5317.578% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 262537.735% |
| OncoCyte Corporation | 413 Thousand USD | -59984.262% |
| Elevation Oncology, Inc. | -39 Thousand USD | 636376.923% |
| Purple Biotech Ltd. | -196 Thousand USD | 126706.122% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2667.038% |
| MacroGenics, Inc. | 50.52 Million USD | -391.12% |
| Verona Pharma plc | -679.62 Thousand USD | 36612.542% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 141898.857% |
| Aditxt, Inc. | -111.66 Thousand USD | 222335.357% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | -44.26 Million USD | 660.634% |
| Curis, Inc. | 9.81 Million USD | -2429.283% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 198955.659% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 108936.842% |
| BeiGene, Ltd. | 2.07 Billion USD | 88.063% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 879496.13% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 27220.0% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 5294.641% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 46396.269% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -126.058% |
| Adicet Bio, Inc. | -6.09 Million USD | 4169.334% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -50750.0% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | -73.91 Million USD | 435.739% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 56884.439% |
| Invivyd, Inc. | -2.02 Million USD | 12336.095% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 182.485% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 240000.23% |
| Moolec Science SA | -143.3 Thousand USD | 173260.741% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -3052.687% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4963060.0% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 29782.775% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -197.486% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -339308.032% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -366.777% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 70396.884% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1359.698% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 25216.194% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 440531.65% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1051.766% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 20.889% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 85082.192% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 37471.687% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -6083.603% |
| ImmunityBio, Inc. | -17.89 Million USD | 1487.077% |
| Korro Bio, Inc. | -3.63 Million USD | 6936.033% |
| Kineta, Inc. | 5.43 Million USD | -4467.421% |
| BioVie Inc. | -229.37 Thousand USD | 108283.471% |
| Codexis, Inc. | 57.33 Million USD | -332.811% |
| Celularity Inc. | 6.75 Million USD | -3573.546% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -490408.006% |
| Cibus, Inc. | 1.42 Million USD | -17350.633% |
| Annexon, Inc. | -3.26 Million USD | 7695.592% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 694.552% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -43.475% |
| NeurAxis, Inc. | 2.15 Million USD | -11405.89% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1273.166% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 13229.524% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -107141.855% |
| Notable Labs, Ltd. | 113 Thousand USD | -219500.0% |
| IN8bio, Inc. | -2.5 Million USD | 10021.951% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 827260.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -13226.96% |
| Lumos Pharma, Inc. | 2 Million USD | -12264.126% |
| Liquidia Corporation | 14.6 Million USD | -1599.644% |
| Mustang Bio, Inc. | -2.22 Million USD | 11252.719% |
| Quantum-Si incorporated | 488 Thousand USD | -50750.0% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 546.639% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 141898.857% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1338.511% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 234921.859% |
| Vaxcyte, Inc. | -75 Million USD | 430.864% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 248.137% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 20727.431% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -683.821% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 12773.544% |
| PepGen Inc. | -1.18 Million USD | 21058.446% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 195492.126% |
| Solid Biosciences Inc. | -76.56 Million USD | 424.11% |
| Palisade Bio, Inc. | 246 Thousand USD | -100773.171% |
| Nutriband Inc. | 862.1 Thousand USD | -28683.965% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 32574.239% |
| Belite Bio, Inc | -399 Thousand USD | 62292.481% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 644.805% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1297.581% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 752063.636% |
| Altimmune, Inc. | -65.37 Million USD | 479.588% |
| Peak Bio, Inc. | 367.76 Thousand USD | -67373.876% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 56884.439% |
| Neurogene Inc. | -3.26 Million USD | 7707.235% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -78.095% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 451278.182% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6821.235% |
| Sesen Bio, Inc. | 40 Million USD | -520.37% |
| argenx SE | 1.1 Billion USD | 77.614% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 20727.431% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -9942.412% |
| Immunome, Inc. | -8.9 Million USD | 2885.989% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 60916.116% |
| Design Therapeutics, Inc. | -537 Thousand USD | 46310.056% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -11463.281% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 83651.515% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2694.062% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1662.415% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 9388.617% |
| Athira Pharma, Inc. | -969 Thousand USD | 25708.669% |
| XOMA Corporation | 3.86 Million USD | -6327.04% |
| Merus N.V. | -83.46 Million USD | 397.322% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 77164.596% |
| Rezolute, Inc. | -36 Thousand USD | 689400.0% |
| Clene Inc. | 533 Thousand USD | -46456.848% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 19326268.224% |
| BeyondSpring Inc. | 1.75 Million USD | -14071.788% |
| Synlogic, Inc. | -1.92 Million USD | 12997.505% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 670770.27% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 4018.951% |
| Peak Bio, Inc. | 367.76 Thousand USD | -67373.876% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1408.59% |
| Krystal Biotech, Inc. | 47.6 Million USD | -421.265% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -75.878% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4838.269% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 9683.894% |
| MannKind Corporation | 136.19 Million USD | -82.206% |
| Ikena Oncology, Inc. | -50.49 Million USD | 591.46% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -128.048% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5759.019% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 98571.429% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4963060.0% |
| Legend Biotech Corporation | 140.92 Million USD | -76.08% |
| Mural Oncology plc | -2.56 Million USD | 9766.848% |
| Disc Medicine, Inc. | -100 Thousand USD | 248248.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1095.663% |
| REGENXBIO Inc. | 53.02 Million USD | -367.948% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4732.26% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 129091.813% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 14427.252% |
| Vaxart, Inc. | -60.76 Million USD | 508.387% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 94531.844% |
| Cellectis S.A. | 18 Thousand USD | -1378500.0% |
| Longeveron Inc. | 221 Thousand USD | -112184.163% |
| Repare Therapeutics Inc. | -80.07 Million USD | 409.914% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 77.296% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 19276.816% |
| Revolution Medicines, Inc. | -399.66 Million USD | 162.089% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 709094.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -506324.49% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.117% |
| Denali Therapeutics Inc. | -93.34 Million USD | 365.84% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 990750.325% |
| Veru Inc. | 7.56 Million USD | -3179.809% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 164436.424% |
| Cingulate Inc. | -582.91 Thousand USD | 42669.967% |
| Passage Bio, Inc. | -3.72 Million USD | 6768.852% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 2060445.4% |
| Exicure, Inc. | -1.42 Million USD | 17538.37% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 64890.601% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -9080.466% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 48502.594% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 165966.57% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 519.126% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -63364.962% |
| OmniAb, Inc. | 14.66 Million USD | -1591.88% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1141.174% |
| Lipocine Inc. | -2.85 Million USD | 8804.449% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 13564.352% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 4449.658% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16574.108% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -229.476% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 381866.154% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -194.377% |
| Ocugen, Inc. | -33.53 Million USD | 839.923% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7947.818% |
| Q32 Bio Inc. | 578 Thousand USD | -42832.18% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 93740.755% |
| Alumis Inc. Common Stock | -1.28 Million USD | 19426.168% |
| Equillium, Inc. | 35.95 Million USD | -590.105% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 14637.083% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -49462.294% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 6002712.482% |
| Dominari Holdings Inc. | 2.03 Million USD | -12070.083% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 135351.893% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1925.289% |
| Bio-Techne Corporation | 773.07 Million USD | 67.901% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1332.808% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 46.147% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 21327.374% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1134.812% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -2021.467% |
| Nkarta, Inc. | -5.86 Million USD | 4328.114% |
| BioCardia, Inc. | -7.24 Million USD | 3523.203% |
| Iterum Therapeutics plc | -1.75 Million USD | 14279.886% |